New blood test could catch deadly fungus in cancer patients faster

NCT ID NCT03349931

Completed Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Nov 20, 2025 · Last updated Jun 12, 2026 · Updated 30 times

Summary

This study tested a new kit (MycoGenie) that uses a blood sample to detect a serious fungal infection called invasive aspergillosis in people with blood cancers. The test also checks if the fungus is resistant to common medicines. The study involved 350 adult patients at high risk for this infection. The goal was to see how accurate the new test is compared to standard methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE ASPERGILLOSIS IN PATIENTS WITH ONCO-HAEMATOLOGICAL DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHRU de Lille, Hôpital Claude Huriez

Lille, 59000, France
CHU Bordeaux, Groupe hospitalier

Bordeaux, 33000, France
CHU de DIJON, Hôpital du bocage

Dijon, 21000, France
CHU de Nantes, Hôpital de Moncousu

Nantes, 44000, France
CHU de RENNES, hôpital de Pontchaillou

Rennes, 35000, France
Hôpital Necker - Enfants maladies (AP-HP)

Paris, Paris, 75015, France

Conditions

Explore the condition pages connected to this study.

INVASIVE ASPERGILLOSIS IN PATIENTS WITH ONCO-HAEMATOLOGICAL DISEASES